Table 2.
Mutational status and local recurrence
|
Local recurrence |
Patients |
|||||
|---|---|---|---|---|---|---|
|
No |
Yes |
|||||
| N=90 | N=8 | N=98 | ||||
|
KRAS Mutation | ||||||
| No |
67 |
(74.4%) |
8 |
(100.0%) |
75 |
(76.5%) |
| yes |
23 |
(25.6%) |
0 |
(0.0%) |
23 |
(23.5%) |
|
BRAF Mutation | ||||||
| No |
89 |
(98.9%) |
7 |
(87.5%) |
96 |
(98.0%) |
| yes |
1 |
(1.1%) |
1 |
(12.5%) |
2 |
(2.0%) |
|
PIK3CA Mutation | ||||||
| No |
86 |
(95.6%) |
8 |
(100.0%) |
94 |
(95.9%) |
| yes |
4 |
(4.4%) |
0 |
(0.0%) |
4 |
(4.1%) |
|
All mutations | ||||||
| At least one mutation | ||||||
| No |
65 |
(72.2%) |
7 |
(87.5%) |
72 |
(73.5%) |
| yes |
25 |
(27.8%) |
1 |
(12.5%) |
26 |
(26.5%) |
| Nb of mutations | ||||||
| 0 |
65 |
(72.2%) |
7 |
(87.5%) |
72 |
(73.5%) |
| 1 |
22 |
(24.4%) |
1 |
(12.5%) |
23 |
(23.5%) |
| 2 | 3 | (3.3%) | 0 | (0.0%) | 3 | (3.1%) |